Replies to post #209535 on Biotech Values

[DewDiligence]

IPXL +37% on appointment of Paul Bisaro as CEO and purported hiring of Morgan Stanley to explore strategic alternatives:

http://finance.yahoo.com/news/impax-board-directors-appoints-paul-120000020.html

Bisaro is the former CEO of Watson Pharmaceuticals (which became Actavis following a tax-inversion merger).